Aoa Dx
Is this your brand? Claim it — free, and takes a minute with your work email.
Overview
Tagline Brand's website · 2026-10-04
Pioneering lipidomics to unlock next-generation biomarkers, utilizing multi-omics and data science for remarkable insights into early cancer diagnosis, focusing on women's health, specifically the first and only technology using these markers for early ovarian cancer detection.
Description Brand's website · 2026-10-04
AOA Dx is a company pioneering lipidomics and an AI-enabled multi-omics platform for life-saving early cancer detection, specifically focusing on women's health, including a novel blood test for early-stage ovarian cancer.
Offerings
Core capabilities Brand's website · 2026-10-04
- GlycoLocate
- (an AI-enabled early detection cancer platform utilizing multi-omics and lipidomics)
- AKRIVIS GD
- (a novel blood test for early-stage ovarian cancer).
Pricing Brand's website · 2026-10-04
Not specified
Audience
Target industry Brand's website · 2026-10-04
Women's health, healthcare providers, patients seeking early cancer diagnosis.
Is this your business?
The information above is publicly sourced — assembled by Optimly from Aoa Dx's website and public pages.
Claim this profile to publish your own verified Business Profile and speak for Aoa Dx across the index.
Claim Aoa Dx — free →Page last updated 2026-10-17.